Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 8
2004 11
2005 5
2006 1
2007 11
2008 3
2009 4
2010 5
2011 6
2012 3
2013 3
2014 5
2015 7
2016 9
2017 10
2018 6
2019 3
2020 3
2021 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

97 results

Results by year

Filters applied: . Clear all
Page 1
Emerging drugs for squamous cell lung cancer.
Cheng H, Shcherba M, Kandavelou K, Liang Y, Liu H, Perez-Soler R. Cheng H, et al. Among authors: perez soler r. Expert Opin Emerg Drugs. 2015 Mar;20(1):149-60. doi: 10.1517/14728214.2015.1001365. Epub 2015 Jan 5. Expert Opin Emerg Drugs. 2015. PMID: 25557559 Review.
Tyrosine kinase inhibitors: a clinical perspective.
Goel S, Mani S, Perez-Soler R. Goel S, et al. Among authors: perez soler r. Curr Oncol Rep. 2002 Jan;4(1):9-19. doi: 10.1007/s11912-002-0043-x. Curr Oncol Rep. 2002. PMID: 11734109 Review.
Cell cycle inhibitors for the treatment of NSCLC.
Shcherba M, Liang Y, Fernandes D, Perez-Soler R, Cheng H. Shcherba M, et al. Among authors: perez soler r. Expert Opin Pharmacother. 2014 May;15(7):991-1004. doi: 10.1517/14656566.2014.902935. Epub 2014 Mar 25. Expert Opin Pharmacother. 2014. PMID: 24666387 Review.
Mouse models in squamous cell lung cancer: impact for drug discovery.
Singh AP, Adrianzen Herrera D, Zhang Y, Perez-Soler R, Cheng H. Singh AP, et al. Among authors: perez soler r. Expert Opin Drug Discov. 2018 Apr;13(4):347-358. doi: 10.1080/17460441.2018.1437137. Epub 2018 Feb 15. Expert Opin Drug Discov. 2018. PMID: 29394493 Review.
HER1/EGFR targeting: refining the strategy.
Pérez-Soler R. Pérez-Soler R. Oncologist. 2004;9(1):58-67. doi: 10.1634/theoncologist.9-1-58. Oncologist. 2004. PMID: 14755015 Free article. Review.
Emerging treatment for advanced lung cancer with EGFR mutation.
Inal C, Yilmaz E, Piperdi B, Perez-Soler R, Cheng H. Inal C, et al. Among authors: perez soler r. Expert Opin Emerg Drugs. 2015;20(4):597-612. doi: 10.1517/14728214.2015.1058778. Epub 2015 Jul 8. Expert Opin Emerg Drugs. 2015. PMID: 26153235 Review.
97 results